Shiori Kinoshita

Papers (14)：

Mori Y, Kinoshita S, Kanamori T, Kataoka H, Joh T, Iida S, Takemoto M, Kondo M, Kuroda J, Komatsu H. The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib. Internal medicine (Tokyo, Japan). 2018. 57. 18. 2753-2757
Masaki A, Ishida T, Suzuki S, Ito A, Narita T, Kinoshita S, Ri M, Kusumoto S, Komatsu H, Inagaki H, et al. Human T-cell lymphotropic/leukemia virus type 1 (HTLV-1) Tax-specific T-cell exhaustion in HTLV-1-infected individuals. Cancer science. 2018. 109. 8. 2383-2390
Kinoshita S, Ishida T, Ito A, Narita T, Masaki A, Suzuki S, Yoshida T, Ri M, Kusumoto S, Komatsu H, et al. Cyclin-dependent kinase 9 as a potential specific molecular target in NK cell leukemia/lymphoma. Haematologica. 2018. 103. 12. 2059-2068
Shiori Kinoshita, Masaki Ri, Takashi Kanamori, Sho Aoki, Takashi Yoshida, Tomoko Narita, Haruhito Totani, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, et al. Potent antitumor effect of combination therapy with sub-optimal doses of akt inhibitors and pomalidomide plus dexamethasone in multiple myeloma. Oncology Letters. 2018. 15. 6. 9450-9456
Takashi Yoshida, Masaki Ri, Shiori Kinoshita, Tomoko Narita, Haruhito Totani, Reham Ashour, Asahi Ito, Shigeru Kusumoto, Takashi Ishida, Hirokazu Komatsu, et al. Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myeloma. PLoS ONE. 2018. 13. 5. e0196780

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page